Dynavax Technologies Corporation (DVAX) |
11.8 0.46 (4.06%) 04-19 16:00 |
Open: | 11.3 |
High: | 11.85 |
Low: | 11.25 |
Volume: | 6,819,083 |
Market Cap: | 1,541(M) |
PE Ratio: | -236 |
Exchange: | NASDAQ Capital Market |
Industry: | Drug Manufacturers - Specialty & Generic |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 12.67 |
Resistance 1: | 12.11 |
Pivot price: | 11.92 |
Support 1: | 11.21 |
Support 2: | 9.33 |
52w High: | 15.15 |
52w Low: | 10.06 |
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
EPS | -0.050 |
Book Value | 4.800 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | -2.75 |
Operating Margin (%) | -11.69 |
Return on Assets (ttm) | -1.9 |
Return on Equity (ttm) | -1.1 |
Thu, 18 Apr 2024
Federated Hermes Inc. Sells 1,264,059 Shares of Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Wed, 17 Apr 2024
StockNews.com Lowers Dynavax Technologies (NASDAQ:DVAX) to Hold - MarketBeat
Wed, 17 Apr 2024
ALNY: 3 Biotech Stocks Paving the Way for Bullish Investment Gains - StockNews.com
Wed, 17 Apr 2024
While shareholders of Dynavax Technologies (NASDAQ:DVAX) are in the black over 5 years, those who bought a week ago aren't so fortunate - Simply Wall St
Sun, 24 Mar 2024
Dynavax Technologies: Still A Believer (NASDAQ:DVAX) - Seeking Alpha
Fri, 23 Feb 2024
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript - Yahoo Finance
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |